Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 125 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/21/2008 First Published: 1/5/2007


1.		Phase IV Randomized Study of Pregabalin in Preventing and Treating Chemotherapy-Induced Peripheral Neuropathy in Patients Undergoing Treatment With Oxaliplatin, Fluorouracil, and Leucovorin Calcium for Advanced Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				18 to 80				Pharmaceutical / Industry				PFIZER-A0081124 RAH-060919, NCT00380874


2.		Paclitaxel Plus Carboplatin With Endostar in Patients of Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 to 75				Pharmaceutical / Industry				XYL014 NCT00708812

Last Modified: 6/10/2008 First Published: 7/1/2002


3.		Phase II/III Randomized Study of Ginger for Chemotherapy-Related Nausea in Patients With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care				Active				18 and over				NCI				URCC-U1902 URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742


4.		A Study of AVE8062 in Advanced-Stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				EFC10145 AVE8062, EudraCT 2007-003592-39, NCT00699517

Last Modified: 9/19/2008 First Published: 1/1/2001


5.		Phase III Randomized Chemoprevention Study of Selenium in Participants With Previously Resected Stage I Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				18 and over				NCI				ECOG-5597 CAN-NCIC-BR16, CALGB-79803, NCCTG-E5597, SWOG-E5597, NCI-P00-0176, NCT00008385, BR16

Last Modified: 9/17/2008 First Published: 2/20/2004


6.		Phase III Randomized Study of Selenium in Patients With Adenomatous Colorectal Polyps

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Active				40 to 80				NCI				UARIZ-00-0430-01 UARIZ-HSC-00142, NCT00078897

Last Modified: 9/17/2008 First Published: 2/20/2004


7.		Phase III Randomized Study of Zoledronate for the Prevention of Skeletal-Related Events in Patients With Prostate Cancer and Bone Metastases Undergoing Androgen Deprivation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-90202 CALGB-90202, ECOG-CALGB-90202, NCT00079001, SWOG-CALGB-90202, CAN-NCIC-PRC2

Last Modified: 6/12/2008 First Published: 5/28/2004


8.		Phase III Randomized Study of Letrozole With or Without Lapatinib Ditosylate in Postmenopausal Women With Stage IV Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				GSK-EGF30008 UCLA-0311034-01, NCT00073528

Last Modified: 9/18/2008 First Published: 7/23/2004


9.		Phase III Randomized Study of Docetaxel With or Without Gefitinib in Patients With Metastatic or Locally Recurrent Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				ECOG-E1302 E1302, NCT00088907

Last Modified: 5/29/2008 First Published: 8/24/2004


10.		Phase III Randomized Study of Synthetic Human Corticotropin-Releasing Factor to Control Symptoms Associated With Peritumoral Edema in Patients With Malignant Brain Tumors Requiring Chronic Administration of High-Dose Dexamethasone

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Pharmaceutical / Industry				NTI-0303 BCM-H-14962, NCT00088166

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute